Skip to main content
Equibles

CITIGROUP INC

Position in LLY — ELI LILLY & Co

CIK 831001 NEW YORK, NY
Back to LLY Full portfolio

Position in LLY

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$1,438,180,257
+$433,807,055 QoQ
Shares Held
1,199,053
+9.8% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#69
of 4,632 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Jun 30, 2026
CallValue
$82,041,018
CallShares
68,400
PutValue
$614,947,812
PutShares
512,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $6,106,168,968 across 18 Drug Manufacturers - General names. LLY ranks #1 (23.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page 		1,199,053 $1,438,180,257
2 JNJ
Johnson & Johnson
 3,925,186 $996,879,486
3 AZN
Astrazeneca PLC
 4,895,753 $928,332,681
4 ABBV
AbbVie Inc.
 2,327,207 $585,618,368
5 MRK
Merck & Co., Inc.
 3,614,905 $464,515,291
6 PFE
Pfizer Inc
 19,228,115 $463,013,007
7 GILD
Gilead Sciences, Inc.
 2,969,159 $375,123,546
8 AMGN
Amgen Inc
 1,020,869 $369,677,081

All Filings in LLY

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $614,947,812 512,700
2026-06-30 $82,041,018 68,400
2026-06-30 $1,438,180,257 1,199,053
2026-03-31 $1,004,373,202 1,091,983
2026-03-31 $530,891,244 577,200
2026-03-31 $61,808,544 67,200
2025-12-31 $708,892,306 659,631
2025-12-31 $109,187,497 101,600
2025-12-31 $390,108,875 363,000
2025-09-30 $502,308,079 658,333
2025-09-30 $266,515,900 349,300
2025-09-30 $63,252,700 82,900
2025-06-30 $65,636,426 84,200
2025-06-30 $828,731,591 1,063,117
2025-06-30 $246,877,151 316,700
2025-03-31 $213,910,690 259,000
2025-03-31 $944,585,005 1,143,690
2025-03-31 $78,131,086 94,600
2024-12-31 $169,068,000 219,000
2024-12-31 $79,902,000 103,500
2024-12-31 $539,515,288 698,854
2024-09-30 $666,604,287 752,426
2024-09-30 $201,728,538 227,700
2024-09-30 $58,117,664 65,600
2024-06-30 $78,858,598 87,100
2024-06-30 $152,013,302 167,900
2024-06-30 $701,338,127 774,634
2024-03-31 $158,548,248 203,800
2024-03-31 $95,455,692 122,700
2024-03-31 $479,676,907 616,583
2023-12-31 $141,416,392 242,600
2023-12-31 $76,245,936 130,800
2023-12-31 $339,901,231 583,101
2023-09-30 $354,456,382 659,908
2023-09-30 $100,604,449 187,300
2023-09-30 $104,256,933 194,100
2023-06-30 $42,442,690 90,500
2023-06-30 $109,928,912 234,400
2023-06-30 $324,121,923 691,121
2023-03-31 $60,510,604 176,200
2023-03-31 $16,758,896 48,800
2023-03-31 $259,384,093 755,297
2022-12-31 $305,047,632 833,828
2022-12-31 $90,033,224 246,100
2022-12-31 $19,974,864 54,600
2022-09-30 $69,778,930 215,800
2022-09-30 $36,118,195 111,700
2022-09-30 $325,300,120 1,006,031
2022-06-30 $237,207,637 731,603
2022-06-30 $10,537,475 32,500